Solventum Corporation
SOLVNYSEHealthcare● Active
$78.53
$-2.48(-3.06%)
Market Cap$13.6B
P/E Ratio—
52W High$88.2
52W Low$62.38
Solventum Corporation (SOLV) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
SOLV · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 5, 2026EPS Actual
$1.48
Est. $1.35 · +9.6%
Revenue
$2.01B
Est. $1.97B · +2.0%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 5, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue🔥 9-Quarter EPS Beat Streak
SOLV reports quarterly as a NYSE-listed Medical - Care Facilities company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.06
Rev. $0.47B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.06
Rev. Est.$0.47B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 6, 2026 | $1.92 | — | — | — | $2.15B | — |
| ▲ Q2 FY2026 | May 5, 2026 | $1.35 | $1.48 | +9.6% | $2.01B | $1.97B | +2.0% |
| ▲ Q1 FY2026 | Feb 26, 2026 | $1.50 | $1.57 | +4.7% | $2.00B | $1.96B | +1.8% |
| ▲ Q4 FY2025 | Nov 6, 2025 | $1.43 | $1.50 | +4.9% | $2.10B | $2.06B | +2.0% |
| ▲ Q3 FY2025 | Aug 7, 2025 | $1.45 | $1.69 | +16.6% | $2.16B | $2.12B | +2.0% |
| ▲ Q2 FY2025 | May 8, 2025 | $1.21 | $1.34 | +10.7% | $2.07B | $2.02B | +2.7% |
| ▲ Q1 FY2025 | Feb 27, 2025 | $1.31 | $1.41 | +7.6% | $2.07B | $2.05B | +1.1% |
| ▲ Q4 FY2024 | Nov 7, 2024 | $1.39 | $1.64 | +18.0% | $2.08B | $2.06B | +1.3% |
Q3 FY2026
Aug 6, 2026
EPS Actual
—
EPS Est.
$1.92
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 5, 2026Beat
EPS Actual
$1.48
EPS Est.
$1.35
EPS Surpr.
+9.6%
Revenue
$2.01B
Q1 FY2026
Feb 26, 2026Beat
EPS Actual
$1.57
EPS Est.
$1.50
EPS Surpr.
+4.7%
Revenue
$2.00B
Q4 FY2025
Nov 6, 2025Beat
EPS Actual
$1.50
EPS Est.
$1.43
EPS Surpr.
+4.9%
Revenue
$2.10B
Q3 FY2025
Aug 7, 2025Beat
EPS Actual
$1.69
EPS Est.
$1.45
EPS Surpr.
+16.6%
Revenue
$2.16B
Q2 FY2025
May 8, 2025Beat
EPS Actual
$1.34
EPS Est.
$1.21
EPS Surpr.
+10.7%
Revenue
$2.07B
Q1 FY2025
Feb 27, 2025Beat
EPS Actual
$1.41
EPS Est.
$1.31
EPS Surpr.
+7.6%
Revenue
$2.07B
Q4 FY2024
Nov 7, 2024Beat
EPS Actual
$1.64
EPS Est.
$1.39
EPS Surpr.
+18.0%
Revenue
$2.08B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $1.99 | $2.04 | $2.09 | 5 |
| Q3 FY2028 | $1.78 | $1.82 | $1.87 | 5 |
| Q2 FY2028 | $2.05 | $2.10 | $2.16 | 6 |
| Q1 FY2028 | $1.74 | $1.79 | $1.84 | 3 |
| Q4 FY2027 | $1.86 | $1.91 | $1.96 | 2 |
| Q3 FY2027 | $1.72 | $1.77 | $1.81 | 2 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $2.2B | $2.2B | $2.3B | 2 |
| Q3 FY2028 | $2.1B | $2.1B | $2.2B | 2 |
| Q2 FY2028 | $2.2B | $2.3B | $2.3B | 2 |
| Q1 FY2028 | $2.1B | $2.2B | $2.2B | 2 |
| Q4 FY2027 | $2.1B | $2.1B | $2.2B | 3 |
| Q3 FY2027 | $2.0B | $2.0B | $2.1B | 3 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 5, 2026 | +9.6% | $67.44 | $69.04 | +2.37% |
| ▲ Q1 FY2026 | Feb 26, 2026 | +4.7% | $75.08 | $76.94 | +2.48% |
| ▲ Q4 FY2025 | Nov 6, 2025 | +4.9% | $67.69 | $66.28 | -2.08% |
| ▲ Q3 FY2025 | Aug 7, 2025 | +16.6% | $72.57 | $71.95 | -0.85% |
| ▲ Q2 FY2025 | May 8, 2025 | +10.7% | $65.49 | $66.63 | +1.74% |
| ▲ Q1 FY2025 | Feb 27, 2025 | +7.6% | $84.04 | $83.44 | -0.71% |
| ▲ Q4 FY2024 | Nov 7, 2024 | +18.0% | $74.14 | $75.07 | +1.25% |
| ▲ Q3 FY2024 | Aug 8, 2024 | +3.3% | $55.90 | $58.66 | +4.94% |
Q2 FY2026+2.37%
Report Date
May 5, 2026
EPS Beat/Miss
+9.6%
Price Before
$67.44
Price After
$69.04
Q1 FY2026+2.48%
Report Date
Feb 26, 2026
EPS Beat/Miss
+4.7%
Price Before
$75.08
Price After
$76.94
Q4 FY2025-2.08%
Report Date
Nov 6, 2025
EPS Beat/Miss
+4.9%
Price Before
$67.69
Price After
$66.28
Q3 FY2025-0.85%
Report Date
Aug 7, 2025
EPS Beat/Miss
+16.6%
Price Before
$72.57
Price After
$71.95
Q2 FY2025+1.74%
Report Date
May 8, 2025
EPS Beat/Miss
+10.7%
Price Before
$65.49
Price After
$66.63
Q1 FY2025-0.71%
Report Date
Feb 27, 2025
EPS Beat/Miss
+7.6%
Price Before
$84.04
Price After
$83.44
Q4 FY2024+1.25%
Report Date
Nov 7, 2024
EPS Beat/Miss
+18.0%
Price Before
$74.14
Price After
$75.07
Q3 FY2024+4.94%
Report Date
Aug 8, 2024
EPS Beat/Miss
+3.3%
Price Before
$55.90
Price After
$58.66
Avg Beat Reaction+1.14%
Beat Rate8 / 8 quarters
Largest Move+4.94% (Q3 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: SOLV ends December
Solventum Corporation (SOLV) most recently reported earnings on May 5, 2026 for Q2 FY2026, posting EPS of $1.48 — beating the analyst consensus of $1.35 by +9.6%. SOLV has beaten EPS estimates for 9 consecutive quarters. The next SOLV earnings date is expected around September 1, 2026.
Each quarter, investors track SOLV earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. SOLV revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
SOLV's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
SOLV earnings · 5 questionsSolventum Corporation's next earnings report is expected around September 1, 2026. SOLV typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; SOLV historically reports after market close (AMC).
SOLV earnings datewhen is SOLV earningsSOLV next earnings datewhen does SOLV report earningsSOLV earnings calendar
▸ Source: FMP · Solventum Corporation SEC filings · US GAAP · Solventum Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026